Literature DB >> 8439690

Isoniazid-associated psychosis: case report and review of the literature.

K A Pallone1, M P Goldman, M A Fuller.   

Abstract

OBJECTIVE: To describe a case of isoniazid-associated psychosis and review the incidence of this adverse effect. DATA SOURCES: Information about the patient was obtained from the medical chart. A MEDLINE search of the English-language literature published from 1950 to 1992 was conducted and Index Medicus was manually searched for current information. STUDY SELECTION: All case reports describing isoniazid-associated psychosis were reviewed. DATA EXTRACTION: Studies were evaluated for the use of isoniazid, symptoms of psychosis, onset of symptoms, and dosage of isoniazid. DATA SYNTHESIS: The case report is compared with others reported in the literature. The incidence of isoniazid-associated psychosis is rare.
CONCLUSIONS: The mechanism of isoniazid-associated psychosis is uncertain. It appears that isoniazid was associated with the psychosis evident in our patient and in the cases reviewed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439690     DOI: 10.1177/106002809302700205

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  3 in total

Review 1.  Pharmacokinetic factors in the modern drug treatment of tuberculosis.

Authors:  J G Douglas; M J McLeod
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

2.  Acute Psychosis after Recent Isoniazid Initiation.

Authors:  Sidharth Arya; Gagandeep Sukhija; Harpreet Singh
Journal:  J Clin Diagn Res       Date:  2015-06-01

3.  Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients.

Authors:  Argiro Pachi; Dionisios Bratis; Georgios Moussas; Athanasios Tselebis
Journal:  Tuberc Res Treat       Date:  2013-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.